TBAL's Microreactor Platform: Benchmarking Innovation in Pharma and Functional Foods
Exhibitor: OMICS BIOTECHNOLOGY CO.,LTD.
Date: 2025-05-26
Booth No.: L318
Taiwan Bioactive Lipid Co., Ltd. (TBAL) is proud to announce the launch of two core innovation platforms: an advanced microreactor CDMO platform and a multi-omics testing platform, aimed at enhancing scalable production of bioactives and enabling biomarker discovery for precision medicine. These platforms collectively support end-to-end R&D services across biotech, pharmaceutical, and functional food industries.
Microreactor CDMO Platform: Scalable, Modular, and Efficient
TBAL’s continuous flow microreactor system incorporates modular Ehrfeld FlowPlate® reactors and real-time process control, providing seamless transition from mg-level pilot trials to kg-scale production. The platform is ideal for the encapsulation of complex bioactives such as liposomes, nucleic acids, nanoparticles, and plant-derived compounds.
Over 30 medical institutions and commercial clients have leveraged TBAL’s microreactor services for drug intermediate synthesis, nanoemulsion development, esterification reactions, and targeted delivery systems. The continuous manufacturing model ensures enhanced process control, cost-efficiency, and reproducible quality—making TBAL a valuable CDMO partner for translational innovation.
Multi-Omics Testing Platform: Empowering Precision Medicine
TBAL’s newly launched multi-omics platform integrates proteomics, lipidomics, metabolomics, and spatial omics with advanced bioinformatics. This holistic approach goes beyond genomics, offering a more dynamic view of disease biology and therapeutic response mechanisms.
Through cross-omic data correlation and customized analytics, the platform enables precise biomarker discovery, supports companion diagnostic development, and accelerates clinical insight. More than 30 academic and medical partners have adopted TBAL’s platform in fields including oncology, neurodegeneration, immunology, and metabolic disorders.
By bridging deep biological data with translational applications, TBAL positions itself as a rare Asia-based service provider combining high-level analytics with practical medical value.
Company Information
If you are interested in our services, feel free to contact us or click the link below for more details:
🌐 Official Website: https://www.t-bal.com/
📘 Facebook: https://www.facebook.com/TBAL2017
📺 YouTube: https://www.youtube.com/@Taiwan-BioActive-Lipid
📞 Phone:+886-4-2247-6758
📧 Email:t-bal_2@t-bal.com.tw
📠 Fax:+886-4-2217-5362
💬 LINE ID:@722hneuu
More Exhibitor's Press Release
- Link-Best debuted at BIO Asia Exhibition. Products attracted attention and Ignited Spark. LINK-BEST BIOSCIENCE CO., LTD. / 2025-08-20
- IOT無線連續監測系統 - 廠房、倉儲、實驗室 溫、濕度測繪 XIN TOP CORPORATION / 2025-08-20
- GoldenBiotech-Advancing First-line treatment of Meta. PanCa GOLDEN BIOTECHNOLOGY CORP. / 2025-08-10
- GlobalBio: 國鼎生技-開發Antroquinonol 造福抗癌研究治療 GOLDEN BIOTECHNOLOGY CORP. / 2025-08-10
- 現場校正、抽檢應用 攜帶式測量儀 XIN TOP CORPORATION / 2025-08-07
- Honya Medical Strengthens Local Presence and Expands Toward Global Clinical Excellence HONYA MEDICAL CO., LTD. / 2025-07-30
- Honya’s MiSaver: A New Frontier in Treating Heart Damage After Heart Attacks HONYA MEDICAL CO., LTD. / 2025-07-30
- AAVnerGene and TFBS Bioscience Announce Collaboration to Develop Innovative AAV Technology Platform TFBS BIOSCIENCE, INC. / 2025-07-25
- Visit Us at BIO Asia–Taiwan 2025! July 24 – July 27 GENERAL BIOLOGICALS CORPORATION (GBC) / 2025-07-25
- GBC CellBio™ a2000 has been recognized with a 2025 Edison Award. GENERAL BIOLOGICALS CORPORATION (GBC) / 2025-07-24
- GBC AI Biotech Building Officially Commissioned. GENERAL BIOLOGICALS CORPORATION (GBC) / 2025-07-24
- Your Invitation to Innovation – Booth M412 Forum MAJOR SCIENCE CO.,LTD / 2025-07-24
- Ecotek Engineering Corp.: Your Integrated Partner for Biopharma Facility and Process Equipment Solut MAJOR SCIENCE CO.,LTD / 2025-07-24
- About major science - Create life sciences research instruments through quality and innovation MAJOR SCIENCE CO.,LTD / 2025-07-24
- MarkerX Unveils MyeloTrak™ at BIO Asia, Redefining Multiple Myeloma Management with Non-invasive, Pr MARKER X CO., LTD. / 2025-07-23
- CancerFree Biotech Selected for OIST Startup Accelerator Program CANCERFREE BIOTECH LTD. / 2025-07-23
- AI Sparks a New Wave in Cancer Research: How a Taiwanese Startup Is Breaking Lab Bottlenecks and Ad CANCERFREE BIOTECH LTD. / 2025-07-23
- Transin Biomedical showcases the innovative strength of smart medical devices TRANSIN BIOMEDICAL CO., LTD. / 2025-07-23
- TaiMed Biologics Hosts Interactive Activities at BIO Asia 2025 to Promote HIV Awareness TAIMED BIOLOGICS INC. / 2025-07-22
- A Pioneer for Over Two Decades, Cell-Bio Biotechnology to Showcase Comprehensive Solutions at BioAsi CELL-BIO BIOTECHNOLOGY CO., LTD. / 2025-07-22